These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 17161355

  • 61. Dendritic cell counts and their subsets during treatment of multiple myeloma.
    Kovarova L, Buchler T, Pour L, Zahradova L, Ocadlikova D, Svobodnik A, Penka M, Vorlicek J, Hajek R.
    Neoplasma; 2007; 54(4):297-303. PubMed ID: 17822319
    [Abstract] [Full Text] [Related]

  • 62. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.
    Dieterlen MT, Bittner HB, Klein S, von Salisch S, Mittag A, Tárnok A, Dhein S, Mohr FW, Barten MJ.
    Cytometry B Clin Cytom; 2012 May; 82(3):151-7. PubMed ID: 22213594
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
    Korczak-Kowalska G, Wierzbicki P, Bocian K, Klosowska D, Niemczyk M, Wyzgal J, Korecka A, Durlik M, Chmura A, Paczek L, Górski A.
    Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
    [Abstract] [Full Text] [Related]

  • 67. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA, Dijkers EC, Uges DR.
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [Abstract] [Full Text] [Related]

  • 68. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R, Sacks JM, Unadkat JV, Solari M, Horibe EK, Thomson AW, Lee AW, Feili-Hariri M.
    Transplantation; 2008 Jan 27; 85(2):237-46. PubMed ID: 18212629
    [Abstract] [Full Text] [Related]

  • 69. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.
    Tucci M, Quatraro C, Lombardi L, Pellegrino C, Dammacco F, Silvestris F.
    Arthritis Rheum; 2008 Jan 27; 58(1):251-62. PubMed ID: 18163476
    [Abstract] [Full Text] [Related]

  • 70. Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial.
    Shenoy S, Hardinger KL, Crippin J, Desai N, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Transplantation; 2007 May 27; 83(10):1389-92. PubMed ID: 17519792
    [Abstract] [Full Text] [Related]

  • 71. Recruitment of myeloid and plasmacytoid dendritic cells in cervical mucosa during Chlamydia trachomatis infection.
    Agrawal T, Vats V, Wallace PK, Singh A, Salhan S, Mittal A.
    Clin Microbiol Infect; 2009 Jan 27; 15(1):50-9. PubMed ID: 19046168
    [Abstract] [Full Text] [Related]

  • 72. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.
    Ko H, Hambly BD, Eris JM, Levidiotis V, Wyburn K, Wu H, Chadban SJ, Yin JL.
    Transpl Immunol; 2008 Nov 27; 20(1-2):99-105. PubMed ID: 18662782
    [Abstract] [Full Text] [Related]

  • 73. Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas.
    Rival-Tringali AL, Euvrard S, Decullier E, Claudy A, Faure M, Kanitakis J.
    Anticancer Res; 2009 Jun 27; 29(6):1927-32. PubMed ID: 19528449
    [Abstract] [Full Text] [Related]

  • 74. Protocol conversion from a calcineurin inhibitor based therapy to sirolimus.
    Oberbauer R.
    Transplantation; 2009 Apr 27; 87(8 Suppl):S7-10. PubMed ID: 19384186
    [Abstract] [Full Text] [Related]

  • 75. Preferential depletion of blood myeloid dendritic cells during acute cardiac allograft rejection under controlled immunosuppression.
    Athanassopoulos P, Vaessen LM, Maat AP, Zondervan PE, Balk AH, Bogers AJ, Weimar W.
    Am J Transplant; 2005 Apr 27; 5(4 Pt 1):810-20. PubMed ID: 15760406
    [Abstract] [Full Text] [Related]

  • 76. Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis.
    Ekong UD, Mathew J, Melin-Aldana H, Wang D, Alonso EM.
    Pediatr Transplant; 2012 Mar 27; 16(2):165-75. PubMed ID: 22360400
    [Abstract] [Full Text] [Related]

  • 77. Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients.
    Li Y, Shi Y, Liao Y, Yan L, Zhang Q, Wang L.
    Int Immunopharmacol; 2015 Sep 27; 28(1):435-43. PubMed ID: 26186486
    [Abstract] [Full Text] [Related]

  • 78. Use of rapamycin slows progression of cardiac transplantation vasculopathy.
    Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR.
    Circulation; 2003 Jul 08; 108(1):48-53. PubMed ID: 12742978
    [Abstract] [Full Text] [Related]

  • 79. Elevated myeloid: plasmacytoid dendritic cell ratio associates with early acute cellular rejection in pediatric small bowel transplantation.
    Gupta A, Ashokkumar C, Ningappa M, Sun Q, Higgs BW, Snyder S, Johnson M, Zeevi A, Abu-Elmagd KM, Thomson AW, Mazariegos GV, Sindhi R.
    Transplantation; 2010 Jan 15; 89(1):55-60. PubMed ID: 20061919
    [Abstract] [Full Text] [Related]

  • 80. South American Heart Transplantation Registry of patients receiving everolimus in their immunosuppressive regimens.
    Bortman GV, Ceruti B, Ahualli L, Colque R, Amuchástegui M, Sgrosso JL, Muñoz J, Vulcano N, Burgos C, Diez F, Rodriguez MC, Perrone SV.
    Transplant Proc; 2010 Jan 15; 42(1):324-7. PubMed ID: 20172342
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.